Form D · Biotechnology
ZYOMYX INC
Fremont, CA · CIK 0001081412
Offering snapshot reported Jul 11, 2013 · SEC filing
- Reported sold
- $14.2M Offering amount: $30.2M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 11, 2013 | Initial | $14,219,999 | No comparison | 2 | SEC filing |
| Jan 29, 2010 | Amendment | $555,016 | $163,350vs Jul 30, 2009 | 8 | SEC filing |
| Jul 30, 2009 | Initial | $391,666 | No comparison | 6 | SEC filing |
| Dec 14, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-199447
The above amounts include shares issued and issuable for cash and upon conversion of debt.
Source: Form D, filed Jul 11, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jennifer Mc Farlane | Executive |
| Mark Mitchnick | Director |
| Michael Richey | Director |
| Craig Taylor | Director |
| Peter Wagner | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6519 Dumbarton Circle
Fremont, CA, 94555
Fremont, CA, 94555